![[PRNewswire] Bruce Markets Links a Korean Brokerage](https://img1.yna.co.kr/etc/inner/PR/2026/10/01/RPR20261001000500353_01_i_P4.jpg?#)
Why uniQure shares are sinking after AMT-130 update
Shares of uniQure plunged on September 29 after the biotech company released four-year data for AMT-130, its experimental gene therapy for Huntington’s disease. The update showed a smaller treatment effect than the company had reported at the three-year mark. (Sources: Reuters, Pluang, StocksToTrade) uniQure stock plunges on Huntington’s data
Shares of uniQure plunged on September 29 after the biotech company released four-year data for AMT-130, its experimental gene therapy for Huntington’s disease. The update showed a smaller treatment effect than the company had reported at the three-year mark. (Sources: Reuters, Pluang, StocksToTrade) uniQure stock plunges on Huntington’s data
What's Your Reaction?
